Summary of Significant Accounting Policies (Details) - Schedule of finite-lived and indefinite-lived intangible assets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 15,518,000
Accumulated Amortization and Impairment	(8,050,916)	$ (7,437,206)
Effect of Foreign Exchange Rates	(260,702)	(639,820)
Net Balance	7,206,382	7,440,974
Trademarks and tradenames [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	1,768,000
Accumulated Amortization and Impairment	(564,679)	(469,011)
Effect of Foreign Exchange Rates	(30,541)	(62,520)
Net Balance	1,172,780	1,236,469
Distributor relationships [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	2,362,000
Accumulated Amortization and Impairment	(502,936)	(417,728)
Effect of Foreign Exchange Rates	(40,799)	(83,525)
Net Balance	1,818,265	1,860,747
A50 – Developed technology [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	349,000
Accumulated Amortization and Impairment	(159,254)	(132,273)
Effect of Foreign Exchange Rates	(6,029)	(12,342)
Net Balance	183,717	204,385
Ares – Developed technology [Member] | Ares Genetics [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,333,000
Accumulated Amortization and Impairment	(1,216,613)	(1,010,495)
Effect of Foreign Exchange Rates	(84,767)	(183,132)
Net Balance	4,031,620	4,139,373
A30 – In-Process Research & Development [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,706,000
Accumulated Amortization and Impairment	(5,607,434)	(5,407,699)
Effect of Foreign Exchange Rates	(98,566)	(298,301)
Net Balance